LPCN logo

Lipocine (LPCN) Free Cash Flow

Annual FCF

-$11.88 M
+$223.40 K+1.85%

December 31, 2023


Summary


Performance

LPCN Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLPCNcash flowmetrics:

Quarterly FCF

-$2.91 M
-$415.20 K-16.62%

September 30, 2024


Summary


Performance

LPCN Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLPCNcash flowmetrics:

TTM FCF

-$5.03 M
-$307.00 K-6.49%

September 30, 2024


Summary


Performance

LPCN TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLPCNcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

LPCN Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.9%-43.4%+57.6%
3 y3 years+22.4%+12.0%+59.3%
5 y5 years+1.6%+12.0%+59.3%

LPCN Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-168.8%+1.9%-132.4%+25.9%-329.4%+59.3%
5 y5-year-168.8%+22.4%-132.4%+58.3%-329.4%+70.5%
alltimeall time<-9999.0%+35.2%-132.4%+61.9%<-9999.0%+75.1%

Lipocine Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.91 M(+16.6%)
-$5.03 M(+6.5%)
Jun 2024
-
-$2.50 M(-203.8%)
-$4.73 M(-14.7%)
Mar 2024
-
$2.41 M(-218.5%)
-$5.54 M(-53.4%)
Dec 2023
-$11.88 M(-1.8%)
-$2.03 M(-22.0%)
-$11.88 M(+0.8%)
Sep 2023
-
-$2.61 M(-21.3%)
-$11.78 M(-4.8%)
Jun 2023
-
-$3.31 M(-15.8%)
-$12.38 M(+2.1%)
Mar 2023
-
-$3.93 M(+103.1%)
-$12.12 M(+0.2%)
Dec 2022
-$12.10 M(+173.9%)
-$1.94 M(-39.5%)
-$12.10 M(+932.2%)
Sep 2022
-
-$3.20 M(+4.6%)
-$1.17 M(-76.3%)
Jun 2022
-
-$3.06 M(-21.9%)
-$4.96 M(+16.3%)
Mar 2022
-
-$3.91 M(-143.5%)
-$4.26 M(-3.4%)
Dec 2021
-$4.42 M(-71.1%)
$8.99 M(-228.8%)
-$4.41 M(-74.2%)
Sep 2021
-
-$6.98 M(+195.4%)
-$17.09 M(+19.7%)
Jun 2021
-
-$2.36 M(-41.8%)
-$14.27 M(-10.7%)
Mar 2021
-
-$4.06 M(+10.3%)
-$15.99 M(+4.5%)
Dec 2020
-$15.30 M(+31.2%)
-$3.68 M(-11.5%)
-$15.30 M(+2.5%)
Sep 2020
-
-$4.16 M(+2.1%)
-$14.93 M(+10.1%)
Jun 2020
-
-$4.08 M(+20.8%)
-$13.56 M(+12.6%)
Mar 2020
-
-$3.38 M(+2.1%)
-$12.04 M(+3.2%)
Dec 2019
-$11.67 M(-3.4%)
-$3.31 M(+18.3%)
-$11.67 M(+10.2%)
Sep 2019
-
-$2.80 M(+9.4%)
-$10.59 M(-5.0%)
Jun 2019
-
-$2.56 M(-14.8%)
-$11.15 M(-1.6%)
Mar 2019
-
-$3.00 M(+34.5%)
-$11.34 M(-6.2%)
Dec 2018
-$12.08 M
-$2.23 M(-33.5%)
-$12.08 M(-14.6%)
Sep 2018
-
-$3.36 M(+22.6%)
-$14.14 M(-7.9%)
Jun 2018
-
-$2.74 M(-26.9%)
-$15.35 M(-11.3%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$3.75 M(-12.8%)
-$17.31 M(+3.6%)
Dec 2017
-$16.70 M(-8.9%)
-$4.30 M(-5.9%)
-$16.70 M(+11.7%)
Sep 2017
-
-$4.57 M(-2.9%)
-$14.95 M(+3.6%)
Jun 2017
-
-$4.70 M(+49.8%)
-$14.44 M(-3.3%)
Mar 2017
-
-$3.14 M(+23.2%)
-$14.93 M(-18.6%)
Dec 2016
-$18.34 M(+19.2%)
-$2.55 M(-37.1%)
-$18.34 M(-1.9%)
Sep 2016
-
-$4.05 M(-22.1%)
-$18.71 M(-7.5%)
Jun 2016
-
-$5.20 M(-20.6%)
-$20.23 M(+7.1%)
Mar 2016
-
-$6.55 M(+124.9%)
-$18.89 M(+22.8%)
Dec 2015
-$15.38 M(-11.4%)
-$2.91 M(-47.7%)
-$15.38 M(-6.6%)
Sep 2015
-
-$5.57 M(+44.2%)
-$16.47 M(+22.9%)
Jun 2015
-
-$3.86 M(+27.1%)
-$13.40 M(-22.0%)
Mar 2015
-
-$3.04 M(-24.1%)
-$17.18 M(-1.0%)
Dec 2014
-$17.36 M(+102.1%)
-$4.00 M(+60.3%)
-$17.36 M(-0.6%)
Sep 2014
-
-$2.50 M(-67.3%)
-$17.48 M(-10.2%)
Jun 2014
-
-$7.65 M(+137.5%)
-$19.45 M(+64.7%)
Mar 2014
-
-$3.22 M(-21.7%)
-$11.81 M(+37.5%)
Dec 2013
-$8.59 M(>+9900.0%)
-$4.11 M(-8.1%)
-$8.59 M(+259.7%)
Sep 2013
-
-$4.48 M(>+9900.0%)
-$2.39 M(>+9900.0%)
Jun 2013
-
-$400.00(+300.0%)
-$3400.00(-94.1%)
Mar 2013
-
-$100.00(-100.0%)
-$58.00 K(-7.9%)
Dec 2012
-$62.90 K(+761.6%)
$2.09 M(-199.9%)
-$63.00 K(-97.1%)
Sep 2012
-
-$2.09 M(+3702.4%)
-$2.15 M(+3479.7%)
Jun 2012
-
-$55.00 K(+978.4%)
-$60.10 K(+1078.4%)
Mar 2012
-
-$5100.00
-$5100.00
Dec 2011
-$7300.00
-
-

FAQ

  • What is Lipocine annual free cash flow?
  • What is the all time high annual FCF for Lipocine?
  • What is Lipocine annual FCF year-on-year change?
  • What is Lipocine quarterly free cash flow?
  • What is the all time high quarterly FCF for Lipocine?
  • What is Lipocine quarterly FCF year-on-year change?
  • What is Lipocine TTM free cash flow?
  • What is the all time high TTM FCF for Lipocine?
  • What is Lipocine TTM FCF year-on-year change?

What is Lipocine annual free cash flow?

The current annual FCF of LPCN is -$11.88 M

What is the all time high annual FCF for Lipocine?

Lipocine all-time high annual free cash flow is -$7300.00

What is Lipocine annual FCF year-on-year change?

Over the past year, LPCN annual free cash flow has changed by +$223.40 K (+1.85%)

What is Lipocine quarterly free cash flow?

The current quarterly FCF of LPCN is -$2.91 M

What is the all time high quarterly FCF for Lipocine?

Lipocine all-time high quarterly free cash flow is $8.99 M

What is Lipocine quarterly FCF year-on-year change?

Over the past year, LPCN quarterly free cash flow has changed by -$881.50 K (-43.39%)

What is Lipocine TTM free cash flow?

The current TTM FCF of LPCN is -$5.03 M

What is the all time high TTM FCF for Lipocine?

Lipocine all-time high TTM free cash flow is -$3400.00

What is Lipocine TTM FCF year-on-year change?

Over the past year, LPCN TTM free cash flow has changed by +$6.84 M (+57.62%)